Levels of Neuregulin-4 and Its Receptor ErbB4 in Periodontitis Patients With and Without Diabetes Type 2

NCT04930588 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2021-06-22

No results posted yet for this study

Summary

The aim of this study is to assess the levels of neuregulin-4 and its receptor ErbB4 in the GCF and saliva in stage III and IV periodontitis patients with and without type 2 diabetes mellitus.

Conditions

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Asmaa samir, master · Cairo University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2023-06-30
Completion
2023-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04930588 on ClinicalTrials.gov